Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-21-014967

Options or other derivatives

  • Director acquired 2,068 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ros Matthew Director 2021-04-01 Grant or award · Stock Option (Right to Buy) +2,068 $5.66 $11,696 2,068 D
Loading xslF345X03/doc4.xml…